17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial

BACKGROUND: Progestational agents may reduce the risk of preterm birth in women with various risk factors. We sought to test the hypothesis that a weekly dose of 17-hydroxyprogesterone caproate (17P) given to women with preterm rupture of the membranes (PROM) will prolong pregnancy and thereby reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Combs, C Andrew, Garite, Thomas J, Maurel, Kimberly, Mallory, Kimberly, Edwards, Rodney K, Lu, George, Porreco, Richard, Das, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260323/
https://www.ncbi.nlm.nih.gov/pubmed/22206581
http://dx.doi.org/10.1186/1756-0500-4-568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260323/
https://www.ncbi.nlm.nih.gov/pubmed/22206581
http://dx.doi.org/10.1186/1756-0500-4-568

Ejemplares similares